The effect of prostaglandin E1 versus ischemia-reperfusion injury of musculocutaneous flaps

Annals of Plastic Surgery

Volumn 47, Issue 3, 2001, Pages 316-321

  Hong, Joon Pio ^a   Chung, Yoon Kyu ^a   Chung, Soon Hee ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; PROSTAGLANDIN E1; PROSTAVASIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LEUKOCYTE ADHERENCE; MYOCUTANEOUS FLAP; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECTUS ABDOMINIS MUSCLE; REPERFUSION INJURY;

EID: 0034843913     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-200109000-00016     Document Type: Article

References (31)

1. Effect of intravenous prostaglandin E1 in experimental flap
2. Efficacy of intravenous infusion of prostacyclin (PGI2) or prostaglandin E1 (PGE1) in augmentation of skin flap blood flow and viability in the pig
3. Effect of prostaglandin E1 on cutaneous microcirculation of flap or replantation
4. Augmentation of skin flap survival by selective intra-arterial infusion of prostaglandin E1: Experimental and clinical studies
5. The relationship between prostaglandin E1 applied area and flap survival area
6. The effects of lipo-prostaglandin E1 on axial pattern flaps in rabbits
7. The effects of intraportal administration of prostaglandin E1 on liver ischemia and hepatectomy in rats
8. Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: Result of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy
9. Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells
10. Cerebral ischemia: II. The no-reflow phenomenon
11. Involvement of neutrophils in ischemia-reperfusion injury of inguinal island flaps in rats
12. Ischemia-reperfusion injury: A review
13. Endothelial cell interaction with granulocytes: Tethering and signaling molecules
14. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen
15. Protective effects of preconditioning in cultured endothelial cells: Effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation
16. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon
17. Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanism for lymphocyte adhesion to cultured endothelial cells
18. Ischemia reperfusion injury in skeletal muscle: CD18-dependent neutrophil endothelial adhesion and arteriolar vasoconstriction
19. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage
20. Stoichiometric conversion of oxygen to superoxide anion during the respiratory burst in neutrophils
21. Reperfusion-induced leukocyte infiltration: Role of elastase
22. Monoclonal antibody to intercellular adhesion molecule 1 protects skin flaps against ischemia-reperfusion injury: An experimental study in rats
23. Source of iron in neutrophil mediated killing of endothelial cells
24. Microcirculatory studies with prostaglandin E1
25. Prostaglandins, cyclic nucleotides and cell function
26. Elevated cyclic AMP inhibited endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not ICAM-1
27. The rat rectus abdominis myocutaneous flap: A true myocutaneous flap model
28. Effect of prostaglandin E1 on forearm blood flow
29. Interaction of chick skin collagen fragment (alpha 1-CB5) with human platelets. Biochemical studies during the aggregation and release reaction
30. Thrombin, collagen, and A23187 stimulated endogenous platelet arachidonate metabolism: Differential inhibition by PGE1, local anesthetics and a serine-protease inhibitor
31. Modulation of macrophage derived interleukin-1 and tumor necrosis factor by prostaglandin E2